Review our expert witness experience in product liability & IP infringement cases

  • Home
  • Regulatory Affairs
    • RA Strategy & Submissions
    • RA Example Presentations
    • RA Peer Reviewed Pubs
  • Expert Witness Support
  • Recent Support Examples
  • Market Access
    • MA Strategy & Submissions
    • MA Example Presentations
    • MA White Papers
  • Pricing
    • Pricing Strategy
    • Market Research
  • About Us
  • Contact Us
  • More
    • Home
    • Regulatory Affairs
      • RA Strategy & Submissions
      • RA Example Presentations
      • RA Peer Reviewed Pubs
    • Expert Witness Support
    • Recent Support Examples
    • Market Access
      • MA Strategy & Submissions
      • MA Example Presentations
      • MA White Papers
    • Pricing
      • Pricing Strategy
      • Market Research
    • About Us
    • Contact Us
  • Home
  • Regulatory Affairs
    • RA Strategy & Submissions
    • RA Example Presentations
    • RA Peer Reviewed Pubs
  • Expert Witness Support
  • Recent Support Examples
  • Market Access
    • MA Strategy & Submissions
    • MA Example Presentations
    • MA White Papers
  • Pricing
    • Pricing Strategy
    • Market Research
  • About Us
  • Contact Us

tJûn17 Life Sciences Advisors

tJûn17 Life Sciences AdvisorstJûn17 Life Sciences AdvisorstJûn17 Life Sciences Advisors


Regulatory, Litigation Support, Reimbursement & Pricing Advisory Services for Innovative Healthcare Products



Schedule a Regulatory or Expert Witness Consultation Directly with Principal Advisor Stephen Amato, PhD, MBA, RAC

tJûn17 Life Sciences Advisors

tJûn17 Life Sciences AdvisorstJûn17 Life Sciences AdvisorstJûn17 Life Sciences Advisors


Regulatory, Litigation Support, Reimbursement & Pricing Advisory Services for Innovative Healthcare Products



Schedule a Regulatory or Expert Witness Consultation Directly with Principal Advisor Stephen Amato, PhD, MBA, RAC

Experienced guidance if commercialization paths are unclear

Bringing innovative healthcare products to market requires more than strong technology. It requires a clear, coordinated strategy across regulatory, reimbursement, pricing, and commercialization.


tJûn17 Life Sciences Advisors supports medical device, IVD diagnostics, biotechnology, and specialty pharmaceutical organizations with regulatory strategy, market access, pricing, and commercialization planning.


We advise manufacturers, investors, and other stakeholders; prepare and support key regulatory submissions, including INDs, NDAs, FDA briefing packages, and global submission documents; and represent clients in interactions with agencies such as the FDA and EMA.


We also support payer dossiers, health technology assessments, and evidence strategies incorporating clinical, economic, and comparative-effectiveness data.




Connect With Us

  • Home
  • Expert Witness Support

tJun17 Life Science Advisors

Copyright © 2026 tJun17 Life Science Advisors - All Rights Reserved.

Powered by

This website uses cookies

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

DeclineAccept